Literature DB >> 24219002

Drug-induced impulse control disorders: a review.

Murad Atmaca1.   

Abstract

The essential characteristic of impulse disorders is the failure to resist an impulse, drive or temptation to perform an act that is harmful to the person or to others. Clearly, impulse control disorders can occur without an induction of any drugs, and they may lead to very problematic situations that affect the adjustment of the patient and need to be treated immediately. However, the subject of the present review is impulsivity induced by a variety of drugs. In this context, the most frequently established agents are dopaminergic agonists that may affect the mesolimbic dopaminergic pathway, such as cocaine and methamphetamine. In Parkinson's disease, the triggering effect of levodopa on pounding has been known since the first description of the condition by Friedman. In this paper, we reviewed the role of a variety of psychopharmacological agents, including dopaminergic ones on the occurrence of impulse control disorders, by searching the PubMed database for relevant articles published in the period between 1980 and 2012 August in detail.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24219002     DOI: 10.2174/1574884708666131111202954

Source DB:  PubMed          Journal:  Curr Clin Pharmacol        ISSN: 1574-8847


  7 in total

1.  New Onset of Compulsive Gambling Associated With Modafinil: A Case Report.

Authors:  Wales T George; Ranji Varghese; Imran S Khawaja
Journal:  Prim Care Companion CNS Disord       Date:  2015-01-01

2.  Network and Pathway-Based Analyses of Genes Associated with Parkinson's Disease.

Authors:  Yanshi Hu; Zhenhua Pan; Ying Hu; Lei Zhang; Ju Wang
Journal:  Mol Neurobiol       Date:  2016-06-27       Impact factor: 5.590

3.  The impact of cognitive training in substance use disorder: the effect of working memory training on impulse control in methamphetamine users.

Authors:  Samantha J Brooks; L Wiemerslage; K H Burch; S A Maiorana; E Cocolas; H B Schiöth; K Kamaloodien; D J Stein
Journal:  Psychopharmacology (Berl)       Date:  2017-03-21       Impact factor: 4.530

Review 4.  Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness.

Authors:  Audrey Verholleman; Caroline Victorri-Vigneau; Edouard Laforgue; Pascal Derkinderen; Celine Verstuyft; Marie Grall-Bronnec
Journal:  Int J Mol Sci       Date:  2020-04-24       Impact factor: 5.923

Review 5.  Impulse Control Behaviors in Parkinson's Disease: Drugs or Disease? Contribution From Imaging Studies.

Authors:  Rosa De Micco; Antonio Russo; Gioacchino Tedeschi; Alessandro Tessitore
Journal:  Front Neurol       Date:  2018-10-25       Impact factor: 4.003

Review 6.  Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacology.

Authors:  Josip Anđelo Borovac
Journal:  Yale J Biol Med       Date:  2016-03-24

Review 7.  Dopamine Agonists and Impulse Control Disorders: A Complex Association.

Authors:  Marie Grall-Bronnec; Caroline Victorri-Vigneau; Yann Donnio; Juliette Leboucher; Morgane Rousselet; Elsa Thiabaud; Nicolas Zreika; Pascal Derkinderen; Gaëlle Challet-Bouju
Journal:  Drug Saf       Date:  2018-01       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.